Early gastric cancer of signet ring cell carcinoma is more amenable to endoscopic treatment than is early gastric cancer of poorly differentiated tubular adenocarcinoma in select tumor conditions.

PubWeight™: 1.71‹?› | Rank: Top 3%

🔗 View Article (PMID 21487870)

Published in Surg Endosc on April 13, 2011

Authors

Hee Man Kim1, Kyung Ho Pak, Moon Jae Chung, Jae Hee Cho, Woo Jin Hyung, Sung Hoon Noh, Choong Bai Kim, Yong Chan Lee, Si Young Song, Sang Kil Lee

Author Affiliations

1: Department of Internal Medicine, Graduate School, Yonsei University College of Medicine, Seoul, Republic of Korea.

Articles citing this

Endoscopic submucosal dissection for early gastric cancer with undifferentiated histology: could we extend the criteria beyond? Surg Endosc (2013) 1.08

Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach. Gastric Cancer (2013) 1.04

Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer. World J Gastroenterol (2015) 0.96

A Risk Prediction Model Based on Lymph-Node Metastasis in Poorly Differentiated-Type Intramucosal Gastric Cancer. PLoS One (2016) 0.95

Endoscopic submucosal dissection for undifferentiated-type early gastric cancer: do we have enough data to support this? World J Gastroenterol (2014) 0.90

Endoscopic submucosal dissection of early gastric cancer. Gut Liver (2011) 0.89

HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach. Dis Markers (2015) 0.84

Clinical significance of a papillary adenocarcinoma component in early gastric cancer: a single-center retrospective analysis of 628 surgically resected early gastric cancers. J Gastroenterol (2014) 0.84

Predictive factors for lymph node metastasis in signet ring cell gastric cancer and the feasibility of endoscopic submucosal dissection. J Gastric Cancer (2013) 0.82

Differences in Clinicopathology of Early Gastric Carcinoma between Proximal and Distal Location in 438 Chinese Patients. Sci Rep (2015) 0.81

Endoscopic predictors for undifferentiated histology in differentiated gastric neoplasms prior to endoscopic resection. Surg Endosc (2015) 0.79

How to Interpret the Pathological Report before and after Endoscopic Submucosal Dissection of Early Gastric Cancer. Clin Endosc (2016) 0.75

Intramucosal Signet Ring Cell Gastric Cancer Diagnosed 15 Months after the Initial Endoscopic Examination. Case Rep Med (2015) 0.75

Effect of World Health Organization (WHO) Histological Classification on Predicting Lymph Node Metastasis and Recurrence in Early Gastric Cancer. Med Sci Monit (2016) 0.75

Differences in Prevalence of Lymphovascular Invasion among Early Gastric Cancers between Korea and Japan. Gut Liver (2017) 0.75

Histology classification challenges for the endoscopic treatment of early gastric cancer. Surg Endosc (2012) 0.75

Clinicopathology of Early Gastric Carcinoma: An Update for Pathologists and Gastroenterologists. Gastrointest Tumors (2017) 0.75

Early gastric cancer with a mixed-type Lauren classification is more aggressive and exhibits greater lymph node metastasis. J Gastroenterol (2016) 0.75

Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: is it really safe? Gastric Cancer (2017) 0.75

Articles cited by this

Japanese Classification of Gastric Carcinoma - 2nd English Edition - Gastric Cancer (1998) 16.63

Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer (2000) 8.85

Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc (2009) 4.76

Endoscopic resection of early gastric cancer. Gastric Cancer (2007) 4.67

Endoscopic mucosal resection for early cancers of the upper gastrointestinal tract. J Clin Oncol (2005) 3.63

Clinical outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Surg Endosc (2009) 1.83

Indication for endoscopic mucosal resection in early signet ring cell gastric cancer. Ann Surg Oncol (2007) 1.77

Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach. Endoscopy (2008) 1.73

Early gastric carcinoma with signet ring cell histology. Cancer (2002) 1.39

Clinicopathological aspects and prognostic value with respect to age: an analysis of 3,362 consecutive gastric cancer patients. J Surg Oncol (2009) 1.30

Endoscopic treatment or surgery for undifferentiated early gastric cancer? Am J Surg (2004) 1.25

Predictive factors for lymph node metastasis and endoscopic treatment strategies for undifferentiated early gastric cancer. J Gastroenterol Hepatol (2008) 1.16

Endoscopic resection for undifferentiated early gastric cancer. Gastrointest Endosc (2009) 1.15

Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer. Endoscopy (2009) 1.13

Risk factors for lymph node metastasis in undifferentiated early gastric cancer. Ann Surg Oncol (2007) 1.13

Safety of extended endoscopic mucosal resection and endoscopic submucosal dissection following the Japanese Gastric Cancer Association treatment guidelines. Br J Surg (2009) 1.11

Clinicopathologic characteristics and prognosis for young gastric adenocarcinoma patients after curative resection. Ann Surg Oncol (2008) 0.97

Endoscopic submucosal dissection for gastric cancer. Curr Treat Options Gastroenterol (2008) 0.94

Is it reasonable to treat early gastric cancer with signet ring cell histology by endoscopic resection? Analysis of factors related to lymph-node metastasis. Eur J Gastroenterol Hepatol (2009) 0.93

Incidence and long-term outcome of young patients with gastric carcinoma according to sex: does hormonal status affect prognosis? Arch Surg (2008) 0.92

Predictive factors for lymph node metastasis in poorly differentiated early gastric cancer and their impact on the surgical strategy. World J Gastroenterol (2008) 0.89

Articles by these authors

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet (2012) 6.83

Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial). Ann Surg (2010) 4.89

Long-term results of laparoscopic gastrectomy for gastric cancer: a large-scale case-control and case-matched Korean multicenter study. J Clin Oncol (2014) 4.79

Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology (2011) 2.36

CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells. Int J Cancer (2009) 2.33

The impact of comorbidity on surgical outcomes in laparoscopy-assisted distal gastrectomy: a retrospective analysis of multicenter results. Ann Surg (2008) 2.33

Defining surgical quality in gastric cancer: a RAND/UCLA appropriateness study. J Am Coll Surg (2013) 2.19

Robotic gastrectomy as an oncologically sound alternative to laparoscopic resections for the treatment of early-stage gastric cancers. Arch Surg (2011) 2.16

Endoscopic enucleation of upper-GI submucosal tumors by using an insulated-tip electrosurgical knife. Gastrointest Endosc (2004) 1.91

An adequate level of training for technical competence in screening and diagnostic colonoscopy: a prospective multicenter evaluation of the learning curve. Gastrointest Endosc (2008) 1.89

Long-term outcomes after laparoscopy-assisted gastrectomy for advanced gastric cancer: a large-scale multicenter retrospective study. Surg Endosc (2011) 1.85

Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res (2011) 1.83

Laparoscopic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer. J Am Coll Surg (2008) 1.80

Role of robotic gastrectomy using da Vinci system compared with laparoscopic gastrectomy: initial experience of 20 consecutive cases. Surg Endosc (2009) 1.80

Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer. Ann Surg Oncol (2002) 1.71

Robot-assisted gastrectomy with lymph node dissection for gastric cancer: lessons learned from an initial 100 consecutive procedures. Ann Surg (2009) 1.71

Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography. Cancer (2005) 1.70

Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT. J Nucl Med (2005) 1.70

Robotic total mesorectal excision for rectal cancer using four robotic arms. Surg Endosc (2007) 1.68

Long-term follow up of gallbladder polyps. J Gastroenterol Hepatol (2008) 1.68

Preliminary study of enteroscopy-guided, self-expandable metal stent placement for malignant small bowel obstruction. J Gastroenterol Hepatol (2012) 1.66

Pulmonary inflammatory pseudotumor--a report of 28 cases. Korean J Intern Med (2002) 1.66

Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer: Short-term Outcomes From a Multicenter Randomized Controlled Trial (KLASS-01). Ann Surg (2016) 1.65

Long-term oncologic outcomes of 714 consecutive laparoscopic gastrectomies for gastric cancer: results from the 7-year experience of a single institute. Surg Endosc (2011) 1.64

Old age and male sex are associated with increased risk of asymptomatic erosive esophagitis: analysis of data from local health examinations by the Korean National Health Insurance Corporation. J Gastroenterol Hepatol (2011) 1.62

Endoscopic papillary large balloon dilatation alone is safe and effective for the treatment of difficult choledocholithiasis in cases of Billroth II gastrectomy: a single center experience. Dig Dis Sci (2013) 1.61

Optimal management of gastric cancer: results from an international RAND/UCLA expert panel. Ann Surg (2014) 1.61

Oral vitamin B12 replacement: an effective treatment for vitamin B12 deficiency after total gastrectomy in gastric cancer patients. Ann Surg Oncol (2011) 1.58

Active locomotion of a paddling-based capsule endoscope in an in vitro and in vivo experiment (with videos). Gastrointest Endosc (2010) 1.55

Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute. Ann Surg Oncol (2007) 1.53

Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint. Mutat Res (2005) 1.51

Laparoscopic resection of a huge intraluminal gastric submucosal tumor located in the anterior wall: eversion method. J Surg Oncol (2005) 1.46

Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics (2006) 1.44

Gastric schwannoma. Yonsei Med J (2008) 1.44

The effect of continuous release of recombinant human epidermal growth factor (rh-EGF) in chitosan film on full thickness excisional porcine wounds. Ann Plast Surg (2008) 1.43

[Assessment of the definition of early extrahepatic bile duct cancer through the prognosis analysis who had received curative resection]. Korean J Gastroenterol (2007) 1.43

Chronic tamoxifen use is associated with a decreased risk of intestinal metaplasia in human gastric epithelium. Dig Dis Sci (2013) 1.43

Risk factors associated with complication following laparoscopy-assisted gastrectomy for gastric cancer: a large-scale korean multicenter study. Ann Surg Oncol (2008) 1.42

[Clinical efficacy of nonsurgical treatment of Crohn's disease-related intraabdominal abscess]. Korean J Gastroenterol (2009) 1.42

Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer. Gut (2012) 1.42

Metabolic syndrome is an independent risk factor for synchronous colorectal neoplasm in patients with gastric neoplasm. J Gastroenterol Hepatol (2012) 1.41

CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics (2006) 1.41

Participation and conflict in the decision-making process for endoscopic resection or surgical gastrectomy for early gastric cancer. J Surg Oncol (2012) 1.40

A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Hum Mol Genet (2003) 1.40

Prognostic impact of lymphatic and/or blood vessel invasion in patients with node-negative advanced gastric cancer. Ann Surg Oncol (2002) 1.40

Incidence and predictive factors of irritable bowel syndrome after acute diverticulitis in Korea. Int J Colorectal Dis (2014) 1.39

Early gastric carcinoma with signet ring cell histology. Cancer (2002) 1.39

Is gastrectomy mandatory for all residual or recurrent gastric cancer following endoscopic resection? A large-scale Korean multi-center study. J Surg Oncol (2008) 1.38

[Massive gastrointestinal bleeding due to aneurysmal rupture of ileo-colic artery in a patient with Behcet's disease]. Korean J Gastroenterol (2007) 1.38

Application of minimally invasive treatment for early gastric cancer. J Surg Oncol (2004) 1.37

Advanced gastric carcinoma with signet ring cell histology. Oncology (2007) 1.35

Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy. Radiology (2008) 1.35

Changes in treatment outcomes of gastric cancer surgery over 45 years at a single institution. Yonsei Med J (2008) 1.34

Safety and efficacy of fast-track surgery in laparoscopic distal gastrectomy for gastric cancer: a randomized clinical trial. World J Surg (2012) 1.31

Clinicopathological aspects and prognostic value with respect to age: an analysis of 3,362 consecutive gastric cancer patients. J Surg Oncol (2009) 1.30

Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer. Gynecol Oncol (2004) 1.29

Long-term outcome of early gastric cancer after endoscopic submucosal dissection: expanded indication is comparable to absolute indication. Dig Liver Dis (2013) 1.28

Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis. Pancreas (2010) 1.27

Intraoperative portable abdominal radiograph for tumor localization: a simple and accurate method for laparoscopic gastrectomy. Surg Endosc (2010) 1.27

Recurrence following laparoscopy-assisted gastrectomy for gastric cancer: a multicenter retrospective analysis of 1,417 patients. Ann Surg Oncol (2010) 1.24

First clinical trial of the "MiRo" capsule endoscope by using a novel transmission technology: electric-field propagation. Gastrointest Endosc (2008) 1.23

Current management and future strategies of gastric cancer. Yonsei Med J (2012) 1.23

Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer. Gastric Cancer (2014) 1.23

The impact of a high body mass index on laparoscopy assisted gastrectomy for gastric cancer. Surg Endosc (2009) 1.21

Endoscopic papillary balloon dilation with large balloon after limited sphincterotomy for retrieval of choledocholithiasis. Yonsei Med J (2006) 1.20

Complications requiring reoperation after gastrectomy for gastric cancer: 17 years experience in a single institute. J Gastrointest Surg (2008) 1.20

The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer. J Clin Gastroenterol (2006) 1.20

Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol (2010) 1.19

Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01. Jpn J Clin Oncol (2008) 1.19